Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6116034 | Diagnostic Microbiology and Infectious Disease | 2013 | 5 Pages |
Abstract
Conversion from Clostridium difficile toxin A/B EIA to tcdB polymerase chain reaction for diagnosis of C. difficile infection (CDI) resulted in significant decreases in laboratory testing volume and largely unchanged C. difficile toxin detection rates. Decreases in healthcare-associated CDI rates (P ⤠0.05) reflected a clinical practice benefit of this conversion.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Maureen Napierala, Erik Munson, Patrice Skonieczny, Sonia Rodriguez, Nancy Riederer, Gayle Land, Mary Luzinski, Denise Block, Jeanne E. Hryciuk,